...
首页> 外文期刊>Vaccine >Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague
【24h】

Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague

机译:鼠疫鼠非人灵长类和小鼠模型中鼠疫耶尔森菌色素沉着缺乏和色素沉着/纤溶酶原激活剂缺乏菌株的毒力测定

获取原文
获取原文并翻译 | 示例
           

摘要

The current human plague vaccine, a killed Yersinia pestis whole-cell preparation, does not protect against aerosol challenge and is reactogenic and antigenically undefined. Live attenuated Y. pestis, such as pigmentation-deficient (Pgm(-)) strains, have been used frequently as vaccines and are efficacious. They are used widely in plague research and assumed to be safe. However, they can cause serious adverse reactions, and their aerosol infectivity is not known. We tested the virulence of a defined Pgm(-) variant of the C092 strain of K pestis in mouse and non-human primate models of pneumonic plague. The ten-fold lower median lethal dose by the aerosol compared to the subcutaneous (s.c.) routes of the Pgm(-) strain in mice suggested that the Pgm- strain might be less attenuated by the former than by the latter route. After exposure of 16 African green monkeys to inhaled doses ranging from 1.1 X 10(4) to 8.1 x 10(7) cfu, eight died and eight survived. The terminal cultures collected from five of the non-survivors were all positive for Y. pestis. Two of the remaining three non-survivors were culture-negative but had pathologic and immunologic evidence of infection with Y pestis, specimens could not be obtained nor the cause of death determined for the third one. The deaths were not dose-related, and there were some differences in the pathology associated with infection by the Pgm- strain compared to the wild-type (wt) strain. However, the Pgm(-) derivative was clearly virulent for monkeys by the aerosol route. A mutant of the Pgm- strain, which has a deletion in the plasminogen activator (Pla) virulence locus (pla), appeared to be more attenuated than was either the Pgm- single mutant (in NHPs and mice) or the Pla(-) single mutant strain (in mice) and has potential as a live vaccine. Published by Elsevier Science Ltd. [References: 35]
机译:当前的人类瘟疫疫苗是一种灭活的鼠疫耶尔森氏菌全细胞制剂,不能抵抗气溶胶攻击,并且具有致反应性和抗原性不确定。活的减毒耶尔森氏菌,例如缺乏色素沉着的(Pgm(-))菌株,已被频繁用作疫苗并且有效。它们被广泛用于瘟疫研究,并被认为是安全的。但是,它们会引起严重的不良反应,其气溶胶感染性尚不清楚。我们在肺鼠疫的小鼠和非人类灵长类动物模型中测试了鼠疫杆菌C092菌株C092株的已定义Pgm(-)变异体的毒力。与小鼠的Pgm(-)皮下(s.c.)途径相比,气雾剂的中位致死剂量低十倍,这表明Pgm-菌株对Pgm-菌株的衰减可能比后一种途径少。在将16只非洲绿猴暴露于1.1 x 10(4)至8.1 x 10(7)cfu的吸入剂量后,八只动物死亡,八只幸存。从五个非幸存者收集的终末培养物均对鼠疫耶尔森氏菌呈阳性。其余三个非幸存者中有两个是培养阴性的,但有病理学和免疫学证据表明感染了Y鼠疫,无法获得标本,也没有确定第三个死因。死亡与剂量无关,与野生型(wt)菌株相比,与Pgm菌株感染相关的病理学存在一些差异。但是,Pgm(-)衍生物通过气雾途径对猴子显然具有毒性。在纤溶酶原激活物(Pla)毒力位点(pla)中缺失的Pgm-菌株突变体似乎比Pgm-单突变体(在NHP和小鼠中)或Pla(-)更弱单突变株(在小鼠中),具有作为活疫苗的潜力。由Elsevier Science Ltd.发布[参考:35]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号